Lersivirine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLersivirine
Drug Alias Name来司韦林lersivirina乐司韦林lersivirinum利司韦林 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[20] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer IncViiv Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncViiv Healthcare
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG